A Study to Evaluate the Efficacy and Safety of ALS-L1023 in Subjects With NASH

Clinical trial NCT04342793 · COMPLETED

Trial details

NCT number: NCT04342793
Sponsor: AngioLab, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Nonalcoholic Steatohepatitis

Start date: 2019-12-04
Primary completion: 2021-05-11
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.